ALEMBIC PHARMA at All Time High; BSE HEALTHCARE Index Up 0.3%

Fri, 15 May 09:23 AM

ALEMBIC PHARMA share price has hit an all-time high at Rs 863 (up 1.8%).

Meanwhile, the BSE HEALTHCARE Index is at 15,156 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE Index today are ALEMBIC PHARMA (up 1.8%) and SANOFI INDIA (up 1.0%).

SUN PHARMA (down 0.1%) and PFIZER (down 0.3%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved up from Rs 529 to Rs 863, registering a gain of Rs 334 (up 62.6%).

The BSE HEALTHCARE has moved up from 13,452 to 15,156, registering a gain of 1,704 points (up 12.7%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 143.8%), J.B.CHEMICALS (up 94.3%) and IPCA LABS (up 69.5%).

REVEALED: The Secret to potentially Making Rs 18,870, Rs 9,425 and Rs 7,315 in a Single Day...

What About the Benchmark Indices?

The BSE Sensex is at 31,296 (down 0.2%). The top gainers among the BSE Sensex stocks today are ONGC (up 1.1%), NTPC (up 0.9%) and TATA STEEL (up 0.9%). Other gainers include BHARTI AIRTEL (up 0.8%) and ASIAN PAINTS (up 0.7%). The most traded stocks in the BSE Sensex are ONGC and TATA STEEL.

In the meantime, NSE Nifty is at 9,182 (down 0.5%). The top gainers in the NSE Nifty include BRITANNIA (up 1.2%), BPCL (up 1.1%) and ONGC (up 0.9%). Other gainers include HINDALCO (up 0.8%) and BHARTI AIRTEL (up 0.7%).

Over the last 12 months, the BSE Sensex has moved down from 37,319 to 31,296, registering a loss of -6,023 points (up -16.8%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit stood at Rs 2 billion for the quarter ended December 2019, compared to a profit of Rs 2 billion a year ago. Net Sales rose 18.8% to Rs 12.1 billion during the period as against Rs 10.2 billion in October-December 2018.

For the year ended March 2019, ALEMBIC PHARMA reported 40.8% increase in net profit to Rs 5.9 billion compared to net profit of Rs 4.2 billion during FY18.

Revenue of the company grew 25.7% to Rs 39 billion during FY19.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 22.1x.

Indian Share Market Update: Top Gainers and Losers

What else is happening in the markets today? Dig in...